Skip to main content

Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.

Research Authors
Mosad E, Hamed HB, Bakry RM, Ezz-Eldin AM, Khalifa NM.
Research Department
Research Journal
J Hematol Oncol
Research Member
Research Rank
1
Research Year
2008